Trial Profile

Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of TAS-102 in Patients with Metastatic Colorectal Cancer; the HGCSG1503 Study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

16 Jul 2018 Status changed from active, no longer recruiting to completed.
20 Jan 2018 Results assessing (n=411) the impact of primary tumor location in mCRC treated TAS-102 in the real-world clinical practice presented at the 2018 Gastrointestinal Cancers Symposium
20 Jan 2018 Results (n=126) comparing efficacy of TAS-102 after administration of regorafenib in the real world practice and other pivotal clinical trials, presented at the 2018 Gastrointestinal Cancers Symposium.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com